Secondary Cytoreduction Followed by Chemotherapy May Improve PFS in Ovarian Cancer For patients with platinum-sensitive relapsed ovarian cancer, research found that secondary cytoreduction followed by chemotherapy was associated with statistically significant longer progression-free survival (PFS) rates when compared to chemotherapy alone, according to data published in Lancet Oncology. With these findings in mind, this cohort […]

Lung cancer risk prediction model lacks efficacy in diverse populations April 09, 2021 2 min read Source/Disclosures Disclosures: Shusted reports no relevant disclosures. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive […]

What to Know About Metastatic Non-Small Cell Lung Cancer Non-small cell lung cancer (NSCLC) is the most common kind of lung cancer. When NSCLC spreads to other parts of the body, it’s known as metastatic NSCLC. There are four stages of NSCLC, with stage 4 being the most severe. While this cancer can spread to […]

‘Patchwork’ tumours prevalent across multiple cancer types | Crick Cancer cells. Researchers at the Francis Crick Institute, as part of an international collaboration of scientists through the Pan-Cancer Analysis of Whole Genomes Consortium, have analysed the whole genomes of tumour samples from over 2,600 patients with different types of cancer. They identified a high prevalence […]

Cancer patients could be at risk if second doses delayed beyond three weeks, oncologists say TORONTO — Experts are ringing the alarm bell over the prevailing policy of delaying the second dose of the vaccine for up to four months, saying this strategy could leave cancer patients unprotected. Citing preliminary research from the U.K., the […]